当前位置: X-MOL 学术Eur. J. Heart Fail. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology
European Journal of Heart Failure ( IF 18.2 ) Pub Date : 2021-10-06 , DOI: 10.1002/ejhf.2356
Giuseppe Rosano 1 , Ewa A Jankowska 2 , Robin Ray 3 , Marco Metra 4 , Magdy Abdelhamid 5 , Stamatis Adamopoulos 6 , Stefan D Anker 7 , Antoni Bayes-Genis 8 , Yury Belenkov 9 , Tuvia B Gal 10 , Michael Böhm 11 , Ovidiu Chioncel 12 , Alain Cohen-Solal 13 , Dimitrios Farmakis 14 , Gerasimos Filippatos 15 , Arantxa González 16 , Finn Gustafsson 17 , Loreena Hill 18 , Tiny Jaarsma 19 , Fadi Jouhra 3 , Mitja Lainscak 20 , Ekaterini Lambrinou 21 , Yury Lopatin 22 , Lars H Lund 23 , Davor Milicic 24 , Brenda Moura 25 , Wilfried Mullens 26 , Massimo F Piepoli 27 , Piotr Ponikowski 2 , Amina Rakisheva 28 , Arsen Ristic 29 , Gianluigi Savarese 23 , Petar Seferovic 30 , Michele Senni 31 , Thomas Thum 32 , Carlo G Tocchetti 33 , Sophie Van Linthout 34 , Maurizio Volterrani 35 , Andrew J S Coats 36
Affiliation  

Patients with heart failure (HF) who contract SARS-CoV-2 infection are at a higher risk of cardiovascular and non-cardiovascular morbidity and mortality. Regardless of therapeutic attempts in COVID-19, vaccination remains the most promising global approach at present for controlling this disease. There are several concerns and misconceptions regarding the clinical indications, optimal mode of delivery, safety and efficacy of COVID-19 vaccines for patients with HF. This document provides guidance to all healthcare professionals regarding the implementation of a COVID-19 vaccination scheme in patients with HF. COVID-19 vaccination is indicated in all patients with HF, including those who are immunocompromised (e.g. after heart transplantation receiving immunosuppressive therapy) and with frailty syndrome. It is preferable to vaccinate against COVID-19 patients with HF in an optimal clinical state, which would include clinical stability, adequate hydration and nutrition, optimized treatment of HF and other comorbidities (including iron deficiency), but corrective measures should not be allowed to delay vaccination. Patients with HF who have been vaccinated against COVID-19 need to continue precautionary measures, including the use of facemasks, hand hygiene and social distancing. Knowledge on strategies preventing SARS-CoV-2 infection (including the COVID-19 vaccination) should be included in the comprehensive educational programmes delivered to patients with HF.

中文翻译:

心力衰竭患者的 COVID-19 疫苗接种:欧洲心脏病学会心力衰竭协会的立场文件

感染 SARS-CoV-2 的心力衰竭 (HF) 患者心血管和非心血管疾病的发病率和死亡率风险更高。不管 COVID-19 的治疗尝试如何,疫苗接种仍然是目前控制这种疾病最有希望的全球方法。对于 HF 患者 COVID-19 疫苗的临床适应症、最佳给药方式、安全性和有效性,存在一些担忧和误解。本文件为所有医疗保健专业人员提供有关在 HF 患者中实施 COVID-19 疫苗接种计划的指导。COVID-19 疫苗适用于所有 HF 患者,包括免疫功能低下(例如接受免疫抑制治疗的心脏移植后)和虚弱综合征患者。最好在最佳临床状态下对 COVID-19 心衰患者进行疫苗接种,包括临床稳定性、充足的水分和营养、心衰和其他合并症(包括缺铁)的优化治疗,但不应允许采取纠正措施延迟接种。已接种 COVID-19 疫苗的 HF 患者需要继续采取预防措施,包括戴口罩、保持手部卫生和保持社交距离。向心衰患者提供的综合教育计划中应包括预防 SARS-CoV-2 感染策略(包括 COVID-19 疫苗接种)的知识。HF 和其他合并症(包括缺铁)的优化治疗,但不应允许纠正措施延迟疫苗接种。已接种 COVID-19 疫苗的 HF 患者需要继续采取预防措施,包括戴口罩、保持手部卫生和保持社交距离。向心衰患者提供的综合教育计划中应包括预防 SARS-CoV-2 感染策略(包括 COVID-19 疫苗接种)的知识。HF 和其他合并症(包括缺铁)的优化治疗,但不应允许纠正措施延迟疫苗接种。已接种 COVID-19 疫苗的 HF 患者需要继续采取预防措施,包括戴口罩、保持手部卫生和保持社交距离。向心衰患者提供的综合教育计划中应包括预防 SARS-CoV-2 感染策略(包括 COVID-19 疫苗接种)的知识。
更新日期:2021-12-06
down
wechat
bug